CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) from its SEC filings: 2025 revenue $4.0 billion (-1% vs the year before), net margin -4%, free cash flow $737.6 million. Insider trades, recent filings and a price chart. Free.
| Exchange | NYSE |
| Industry | Services-Commercial Physical & Biological Research |
| Revenue (2025) | $4.0 billion |
| Revenue growth | -1% |
| Net income | -$144.3 million |
| Net margin | -3.6% |
| Free cash flow | $737.6 million |
| Diluted EPS | $-2.91 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | -3% |
| Cash | $192.0 million |
| Long-term debt | $1.6 billion |
| Share count, 1 year | -3% |
| Fundamentals check | Weak fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.